Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.23.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jan. 03, 2022
Mar. 29, 2023
Jul. 28, 2016
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Related party payables       $ 1,342,869   $ 1,077,088
Common share issued for services, shares       33,697 17,500  
Per share value       $ 0.001   $ 0.001
Common Stock, Shares Issued       8,519,489   7,718,636
Ownership percentage       50.00%    
Lucido Subscription Agreement [Member]            
Purchase price $ 4.35 $ 1.75        
Subscription aggregate amount receivable $ 500,000 $ 300,000        
Per share value $ 0.001 $ 0.001        
Common Stock, Shares Issued 114,943 171,296        
Board of Directors [Member]            
Common Stock, Shares Issued       4,285    
Common share issued, value       $ 58,949 $ 50,000  
Minimum [Member] | Joseph Galligan [Member]            
Ownership percentage   15.00%   15.00%    
Maximum [Member] | Joseph Galligan [Member]            
Ownership percentage   20.00%   20.00%    
BioCorRx Pharmaceuticals [Member]            
Ownership percentage held by Company     75.80%